A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Glaukos Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 8,374 shares of GKOS stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,374
Previous 9,234 9.31%
Holding current value
$1.26 Million
Previous $1.09 Million 0.18%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$113.62 - $135.39 $97,713 - $116,435
-860 Reduced 9.31%
8,374 $1.09 Million
Q2 2024

Aug 14, 2024

SELL
$89.48 - $118.35 $227,279 - $300,609
-2,540 Reduced 21.57%
9,234 $1.09 Million
Q1 2024

May 14, 2024

SELL
$76.4 - $96.33 $2.46 Million - $3.1 Million
-32,158 Reduced 73.2%
11,774 $1.11 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $1.42 Million - $2.03 Million
23,830 Added 118.55%
43,932 $3.49 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $2.8 Million - $3.2 Million
-40,503 Reduced 66.83%
20,102 $1.51 Million
Q2 2023

Aug 11, 2023

SELL
$45.44 - $71.21 $477,710 - $748,630
-10,513 Reduced 14.78%
60,605 $4.32 Million
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $153,974 - $184,152
3,509 Added 5.19%
71,118 $3.56 Million
Q4 2022

Feb 13, 2023

SELL
$40.82 - $57.75 $870,731 - $1.23 Million
-21,331 Reduced 23.98%
67,609 $2.95 Million
Q3 2022

Nov 10, 2022

SELL
$46.84 - $58.49 $223,473 - $279,055
-4,771 Reduced 5.09%
88,940 $4.74 Million
Q2 2022

Aug 11, 2022

BUY
$34.86 - $63.77 $245,902 - $449,833
7,054 Added 8.14%
93,711 $4.26 Million
Q1 2022

May 13, 2022

BUY
$44.33 - $57.82 $965,507 - $1.26 Million
21,780 Added 33.57%
86,657 $5.01 Million
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $835,723 - $1.18 Million
20,753 Added 47.03%
64,877 $2.88 Million
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $128,867 - $228,852
-2,717 Reduced 5.8%
44,124 $2.13 Million
Q2 2021

Aug 13, 2021

BUY
$73.06 - $97.7 $3.42 Million - $4.58 Million
46,841 New
46,841 $3.97 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.